SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Trading Statement

1 Jun 2007 11:31

Sabien Technology Group PLC01 June 2007 SABIEN TECHNOLOGY GROUP PLC ("SABIEN") TRADING UPDATE Sabien Technology Group Plc is updating the market ahead of the financial yearending 30 June 2007. On announcing its unaudited interim results for the six month period to 31December 2006 on 31 March 2007, the Board made reference to the fact that thethree month delay in admission of its shares to trading on AIM led to thedeferment of the recruitment of sales staff and the implementation of othercorporate initiatives which, in turn, meant that certain predicted revenueswould be deferred into the financial year ending 30 June 2008. In addition, the Company is also finding that whilst it is in negotiation with asignificant number of potential users of the M2G product, the time taken inconverting leads into purchase orders is proving to take significantly longerthan anticipated at the time of flotation due to these users often being unableto measure energy consumption accurately and thus quantify savings derived fromusing M2G. Following a detailed review of the current order book and sales pipeline, theBoard now confirms that the results for the financial year ending 30 June 2007are likely to be considerably below market expectations and the Company islikely to report a loss before tax for the full year of around £0.75 million. The Board is pleased to report however that, during the company's second halfyear, a number of major organisations have committed to the use of Sabien's M2Gtechnology and the company will continue to implement its strategy to achievesubstantial market penetration. Future Developments As announced on 24 May 2007, the company's main client, RBS, continues to enjoysubstantial environmental and financial benefits as a result of the adoption ofSabien's M2G technology across 200 of their commercial sites and a furtherroll-out of units is scheduled to continue throughout the next 12 months. In addition, Sabien is currently in advanced negotiations with a prospectiveItalian licensee. Whilst there can be no guarantee of positive outcomes, thesenegotiations may result in unbudgeted licence and other revenue streams and theBoard will update the market accordingly. Further, the Board confirms that the company is launching a strategic initiativetargeting a number of large multi-site commercial organisations. Theseorganisations are being approached to participate in a three month contractedpilot scheme under which the proven energy and emission reduction advantages ofSabien M2G technology will be made available to them. The company is also looking at ways of incorporating meter and monitoring intoits product offering in order to counter the long sales lead times due tocustomers' inability to measure their energy consumption. Following the results of these initiatives, the Board will have a clearer viewof the likely target for the year ending 30 June 2008 and will update the marketaccordingly. Contact: Sabien Technology Group Plc Alan O'Brien CEO 020 7993 3700 Gus Orchard Finance Director Gavin Anderson Ken Cronin 020 7554 1400 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Mar 20217:00 amRNSCorporate Update - US Subsidiary Established
8th Mar 202110:59 amRNSCorporate Update - Contract win
5th Mar 202112:32 pmRNSNotice of Annual General Meeting
5th Mar 20217:00 amRNSAppointment of Chief Financial Officer
3rd Mar 20214:33 pmRNSHolding(s) in Company
3rd Mar 202110:00 amRNSHolding(s) in Company
1st Mar 20215:06 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSHolding(s) in Company
26th Feb 20215:00 pmRNSTotal Voting Rights
26th Feb 202110:47 amRNSSignificant investment in emerging technology
24th Feb 20212:10 pmRNSHolding(s) in Company
24th Feb 202112:16 pmRNSHolding(s) in Company
23rd Feb 20213:45 pmRNSChange of Registered Office
22nd Feb 202110:35 amRNSResult of General Meeting and Total Voting Rights
12th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 202111:03 amRNSHolding(s) in Company
10th Feb 202111:38 amRNSHolding(s) in Company
3rd Feb 20214:11 pmRNSPlacing and Notice of General Meeting
1st Feb 20217:00 amRNSAppointment of Non-Executive Director
28th Jan 20214:32 pmRNSHolding(s) in Company
28th Jan 20218:14 amRNSHolding(s) in Company
27th Jan 20211:28 pmRNSChange of Substantial Shareholding
27th Jan 20211:26 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSBoard Changes
20th Jan 20217:30 amRNSRestoration - Sabien Technology Group PLC
20th Jan 20217:00 amRNSWithdrawal from acquisition and other matters
12th Jan 20215:38 pmRNSFrequently asked questions regarding the GM
5th Jan 20217:00 amRNSPosting of Circular and Notice of General Meeting
21st Dec 20205:23 pmRNSHolding(s) in Company
21st Dec 20205:20 pmRNSHolding(s) in Company
2nd Dec 20205:14 pmRNSPosting of Annual Report and Accounts
19th Nov 20207:00 amRNSFinal Results & Update on Proposed Acquisition
5th Nov 20207:00 amRNSChange of Registered Office
2nd Nov 20207:00 amRNSUpdate on Acquisition
14th Sep 20203:30 pmRNSCorporate Update - Contract win
27th Jul 20207:00 amRNSChange of Adviser
27th Jul 20207:00 amRNSUpdate re. Suspension
6th Jul 20207:00 amRNSTrading Update
29th May 202011:15 amRNSManagement Change, Furlough Update
31st Mar 20207:00 amRNSSabien furloughs staff in response to C19 lockdown
20th Mar 20207:00 amRNSHalf-year Report
18th Mar 20207:00 amRNSChange of Adviser
20th Jan 20207:30 amRNSSuspension - Sabien Technology Group plc
20th Jan 20207:30 amRNSStatement re Press Comment
10th Jan 20202:00 pmRNSPrice Monitoring Extension
10th Jan 20201:30 pmRNSIssue of Equity
10th Jan 202010:15 amRNSHolding(s) in Company
8th Jan 20201:15 pmRNSResult of Meeting
19th Dec 201912:30 pmRNSApplication for admission
17th Dec 20194:35 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.